Search Results - "Amin, Hilman Zulkifli"
-
1
CTLA-4 Protects against Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice
Published in Scientific reports (30-05-2019)“…Vascular inflammation via T-cell-mediated immune responses has been shown to be critically involved in the pathogenesis of abdominal aortic aneurysm (AAA)…”
Get full text
Journal Article -
2
Oral administration of the lactic acid bacterium Pediococcus acidilactici attenuates atherosclerosis in mice by inducing tolerogenic dendritic cells
Published in Heart and vessels (01-06-2017)“…The intestinal microbiota appears to play an important role in the development of atherosclerosis. We investigated the effect of the probiotic lactic acid…”
Get full text
Journal Article -
3
Takotsubo Cardiomyopathy: A Brief Review
Published in Journal of medicine and life (01-01-2020)“…Takotsubo cardiomyopathy is a reversible cardiomyopathy with a unique morphological feature of the left ventricle characterized by an apical ballooning…”
Get full text
Journal Article -
4
Link between the Platelet-to-Lymphocyte Ratio and Coronary Artery Disease Severity
Published in Journal of Tehran University Heart Center (01-04-2016)Get full text
Journal Article -
5
Novel UV-B Phototherapy With a Light-Emitting Diode Device Prevents Atherosclerosis by Augmenting Regulatory T-Cell Responses in Mice
Published in Journal of the American Heart Association (16-01-2024)“…Ultraviolet B (UV-B) irradiation is an effective treatment for human cutaneous disorders and was shown to reduce experimental atherosclerosis by attenuating…”
Get full text
Journal Article -
6
Depletion of Foxp3+ regulatory T cells augments CD4+ T cell immune responses in atherosclerosis-prone hypercholesterolemic mice
Published in Heliyon (01-07-2022)“…Compelling evidence suggests a crucial role for Foxp3+ regulatory T cells (Tregs) in the control of atherosclerosis. Although suppression of pro-inflammatory…”
Get full text
Journal Article -
7
Impact of CD14 ++ CD16 + monocytes on plaque vulnerability in diabetic and non-diabetic patients with asymptomatic coronary artery disease: a cross-sectional study
Published in Cardiovascular diabetology (08-08-2017)“…Previously, we have reported that daily glucose fluctuations could affect coronary plaque vulnerability, but the underlying mechanisms remained unclear. This…”
Get full text
Journal Article -
8
Regulatory T Cell Immunity in Atherosclerosis
Published in Acta medica Indonesiana (01-01-2017)“…Atherosclerosis is a chronic inflammatory disorder involving innate and adaptive immunity process. Effector T cell (Teff) responses promote atherosclerotic…”
Get full text
Journal Article -
9
Cytotoxic T Lymphocyte-Associated Antigen-4 Protects Against Angiotensin II-Induced Kidney Injury in Mice
Published in Circulation Reports (10-06-2020)“…Background:Chronic inflammation caused by pathogenic immune response is crucial in the pathogenesis of kidney disease. In particular, T-cell-mediated adaptive…”
Get full text
Journal Article -
10
Ultraviolet B Exposure Inhibits Angiotensin II–Induced Abdominal Aortic Aneurysm Formation in Mice by Expanding CD4+Foxp3+ Regulatory T Cells
Published in Journal of the American Heart Association (01-09-2017)“…Background Pathogenic immune responses are known to play an important role in abdominal aortic aneurysm (AAA) development. Ultraviolet B (UVB) irradiation has…”
Get full text
Journal Article -
11
Tolvaptan: A Novel Diuretic in Heart Failure Management
Published in Journal of Tehran University Heart Center (2016)“…Heart failure (HF) is still a major problem worldwide with high morbidity and mortality rates. The recently developed medication for HF is still incapable of…”
Get full text
Journal Article -
12
Cardiac Resynchronization Therapy in Heart Failure Management
Published in Majalah kardiologi Indonesia (02-05-2016)“…Heart failure (HF) is a worldwide health problem with high prevalence rate. The prevalence is over 23 million worldwide. It is a chronic disease characterized…”
Get full text
Journal Article -
13
Hepatopulmonary Syndrome: A Brief Review
Published in Revue roumaine de médecine interne (1990) (01-06-2016)“…Hepatopulmonary syndrome (HPS) is a pulmonary complication of liver disease characterized by arterial hypoxemia. Mechanisms related to this event are…”
Get full text
Journal Article -
14
Diagnostic approach to cardiac amyloidosis
Published in Kobe journal of the medical sciences (2014)“…Amyloidosis is a relatively rare disease that may be underdiagnosed and could affect the entire human body. Many organs may be affected, which could increase…”
Get full text
Journal Article -
15
Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis
Published in Circulation (New York, N.Y.) (27-11-2018)“…BACKGROUND:It is increasingly recognized that gut microbiota play a pivotal role in the development of atherosclerotic cardiovascular disease. Previously, we…”
Get full text
Journal Article -
16
The Gut Microbiota Profile in Heart Failure Patients: A Systematic Review
Published in Journal of gastrointestinal and liver diseases : JGLD (29-09-2023)“…Background and Aims: Traditional cardiovascular risk factors are established predictors of heart failure (HF). However, the human gut microbiota is suggested…”
Get full text
Journal Article -
17
Galectin-3: a novel biomarker for the prognosis of heart failure
Published in Clujul medical (2017)“…Heart failure (HF) is still a global burden which carries substantial risk of morbidity and mortality. Thus, appropriate approach of diagnosis and layering the…”
Get full text
Journal Article -
18
Paramount Importance of Angiotensin Receptor Neprilysin Inhibitor in Heart Failure Management
Published in Acta medica Iranica (01-01-2017)Get full text
Journal Article -
19
Paramount Importance of Angiotensin ReceptorNeprilysin Inhibitor in Heart Failure Management
Published in Acta medica Iranica (01-12-2016)Get full text
Journal Article -
20
Tolvaptan: A Novel Diuretic in Heart Failure Management
Published in The journal of Tehran Heart Center (13-01-2016)“…Heart failure (HF) is still a major problem worldwide with high morbidity and mortality rates. The recently developed medication for HF is still incapable of…”
Get full text
Journal Article